Nucleic Acid Labeling Market Size, Share, Outlook, Opportunities And Strategies 2024-2033

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Nucleic Acid Labeling Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The nucleic acid labeling market size has grown strongly in recent years. It will grow from $2.34 billion in 2023 to $2.55 billion in 2024 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to increased healthcare expenditure, rise in r&d spending, increased genomics research and disease diagnosis, increased demand for personalized medicine, healthcare infrastructure.

The nucleic acid labeling market size is expected to see strong growth in the next few years. It will grow to $3.58 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to rising health awareness among people, growing penetration of key global players, increasing focus on patient-centered approaches, growing biotechnology sector, increasing use of dna sequencing. Major trends in the forecast period include advancements in tools for synthetic biology, advancements in labeling techniques, development of novel labeling techniques, innovative fluorescent dyes, integration of new labeling technologies in research and therapeutics.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=12647&type=smp

Market Segmentation:
The nucleic acid labeling market covered in this report is segmented -
1) By Product Type: Kits, Reagents, Instruments
2) By Labeling Type: Radioisotope Or Radioactive Labels, Non-Radioactive Labels
3) By Method: Enzyme-Based, Chemical-Based
4) By Application: DNA Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization (FISH), Microarrays, Blotting, In Situ Hybridization, Other Applications
5) By End User: Hospitals Or Clinics, Diagnostic Centers, Other End Users

Major Driver - Nucleic Acid Labeling Market Surges Amidst Rising Infectious Diseases
The rise in infectious diseases is expected to propel the growth of the nucleic acid labeling market going forward. Infectious diseases are conditions caused by organisms, usually microscopic, such as parasites, fungi, viruses, and bacteria that are transmitted from one individual to another through indirect or direct contact. Nucleic acid labeling techniques offer improved specificity, sensitivity, multiplexing capability, visualization, real-time monitoring, and automation for the detection of infectious diseases such as tuberculosis, hepatitis, and gonorrhea. For instance, in March 2023, according to the Centers for Disease Control and Prevention, a US-based national public health organization, in the United States, 8,300 cases of tuberculosis (TB) were reported in 2022, a rise from 7,874 cases in 2021. Additionally, tuberculosis (TB) incidence increased slightly in 2022 (2.5 incidents per 100,000 people). Therefore, the rise in infectious diseases propels the growth of the nucleic acid labeling market.

Competitive Landscape:
Major companies operating in the nucleic acid labeling market report are General Electric Company, F. Hoffman-La Roche AG, Thermo Fisher Scientific Inc., Merck Group, Roche Diagnostics Corporation, GE Healthcare Bio Sciences AB, Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Cytiva, Qiagen N.V., Biotium Inc., Illumina Inc., LGC Group, Promega Corporation, Kaneka Eurogentec SA, New England Biolabs, Enzo Biochem Inc., LI-COR Biosciences Inc., Eurogentec S.A., OriGene Technologies Inc., BaseClear B.V., Vector Laboratories Inc., Bio-Synthesis Inc., BioCat GmbH, Jena Bioscience GmbH, LubioScience GmbH, GeneCopoeia Inc., Mirus Bio LLC, Daicel Arbor Biosciences.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/nucleic-acid-labeling-global-market-report

Top Trend - Nucleic Acid Labeling Market Embraces Cutting-Edge Nanotechnology
Technological advancements are a key trend gaining popularity in the nucleic acid labeling market. Major companies operating in the nucleic acid labeling market are focused on advancements in nanotechnology to sustain their position in the market. For instance, in January 2023, Cambridge Nucleomics, a UK-based biotechnology company, developed a new technology nano bait. This technology is used for the diagnosis of highly multiplexed detection of nucleic acid signatures caused by respiratory pathogens and provides a faster solution for viral RNA detection compared to the other techniques.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Nucleic Acid Labeling Market Characteristics
3. Nucleic Acid Labeling Market Trends And Strategies
4. Nucleic Acid Labeling Market - Macro Economic Scenario
5. Nucleic Acid Labeling Market Size And Growth
…..
27. Nucleic Acid Labeling Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

"Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model "

"About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.